A Study of Non-invasive Measurement of Blood Glucose and Blood Pressure
Not Applicable
Completed
- Conditions
- Diabetes
- Registration Number
- NCT05904769
- Lead Sponsor
- Mayo Clinic
- Brief Summary
The purpose of this research is to compare blood glucose, blood pressure and electrocardiogram (ECG) readings on the LIFELEAF Smartwatch compared to standard methods of measurement.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 87
Inclusion Criteria
- Diabetic patients on insulin undergoing four times daily blood sugar checks as part of standard of care.
- Patients undergoing continuous monitoring for heart rate and blood pressure as part of their routine care.
- Patients undergoing catheter ablation for atrial fibrillation.
Exclusion Criteria
- Patients unable to provide informed consent.
- Patients without arms as these are needed to wear the wrist-based sensor.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Systolic blood pressure Baseline Measured in millimeters of mercury (mmHg)
Blood glucose level Baseline Measured in milligrams per deciliter (mg/dL)
Diastolic blood pressure Baseline Measured in millimeters of mercury (mmHg)
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms enable photoplethysmography to extrapolate QRS complexes for ECG monitoring in diabetes?
How does the LIFELEAF Smartwatch compare to traditional glucometers in measuring blood glucose levels in type 2 diabetes patients?
Which biomarkers correlate with accurate non-invasive blood pressure readings using wrist-worn photoplethysmography sensors in diabetic populations?
What adverse events are associated with long-term use of photoplethysmography-based wearable devices for glucose and blood pressure monitoring in clinical settings?
Are there combination approaches integrating photoplethysmography with other non-invasive technologies to improve diabetes management outcomes?
Trial Locations
- Locations (1)
Mayo Clinic Minnesota
🇺🇸Rochester, Minnesota, United States
Mayo Clinic Minnesota🇺🇸Rochester, Minnesota, United States